Clinical Trial

Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the design, safety and efficacy of OralViome Cancer Testing system in the early detection of Oral and Throat Cancers using saliva metatranscriptomic analysis. This study will recruit only at existing clinical sites and will NOT use any additional clinical sites.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-07-05; most recent amendment 2025-01-27.
Trial Details
NCT Number NCT05451303
Lead Sponsor Viome
Collaborators: New York Medical College
Conditions Oral Squamous Cell Carcinoma, Oropharynx Squamous Cell Carcinoma, Premalignant Lesion
Enrollment 475 participants
Start Date 2022-05-27
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-01-29